Enfortumab Vedotin Schedule De-escalation in Metastatic Urothelial Carcinoma
ACTIVE_NOT_RECRUITING
Status
Conditions
- Urothelial Carcinoma
- Metastatic Urothelial Carcinoma
- Locally Advanced Urothelial Carcinoma
Interventions
- DRUG: Enfortumab vedotin
- DRUG: Pembrolizumab
Sponsor
Fox Chase Cancer Center